SGLT2 Inhibitor Reduces CV, Renal Events in Type 2 Diabetes
June 17, 2019
ADA 2019—Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.
Cardiovascular Disease
Aspirin for Primary CVD Prevention: Does this Patient Qualify?
June 12, 2019
Daily aspirin for primary prevention of heart disease is a practice under scrutiny. Based on the new 2019 ACC/AHA CVD prevention guidelines, is this patient a candidate?
REDUCE-IT Trial: A 5-question Quiz
May 30, 2019
Test your knowledge of the key elements and outcomes of the highly buzzed about REDUCE-IT trial with this 5-question quiz.
9 Questions on Primary CV Disease Prevention
May 2, 2019
How much do you know about the 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease? Take this 9-question quiz to find out.
The Evolution of Exercise: 10 Main Events
May 1, 2019
Man's need for exercise began with foraging for subsistence and is just as essential in our age of sitting and screen time. Trace the evolution, here.
Primary Cardiovascular Prevention: 2019 ACC/AHA Guideline Update
April 17, 2019
Eighty percent of all cardiovascular events are preventable. The ACC/AHA 2019 guidelines are a single source of best practices to help achieve that goal. Review them here, at-a-glance.
ACC.19: 3 Studies in Cardioprotection
March 25, 2019
Dapagliflozin, icosapent ethyl, and bempedoic acid were found to reduce clinical or surrogate CV endpoints in studies presented at ACC.19, March 16-18, in New Orleans, LA.
Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials
February 21, 2019
Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.
Quiz #3: AHA/ACC 2018 Lipid Guidelines
February 6, 2019
What approach is now AHA/ACC guideline-recommended for a patient with primary hypercholesterolemia, with an LDL-C of 192 mg/dL? Take Quiz #3.
AHA/ACC 2018 Guidelines on Treatment of Blood Cholesterol: Quiz #2
January 24, 2019
How will changes in the AHA/ACC update to the 2013 guidelines help optimize care for patients with ASCVD? Try part 2 of our 3-part quiz and find out.
